EUVIMEDEUVIMED entdecken
Crossref

The efficacy of anti-radiation blood serum in combination with bifidobacteria metabolism products on small laboratory animals: a pilot experimental study

Timur R. Gaynutdinov, Sergey V. Boichuk, Sergey A. Ryzhkin

Kazan medical journal · 15.05.2026 · 107 (3) · 352-361

DOI: 10.17816/kmj690573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 15.05.2026. Verfasst von Timur R. Gaynutdinov und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiation accidents at nuclear power facilities, the use of nuclear weapons in military conflicts, and acts of radiological terrorism can lead to severe radiation injuries requiring medical care, including the use of modern agents for early pathogenetic therapy.

Aim

To evaluate the effectiveness of anti-radiation blood serum in combination with bifidobacteria metabolism products in experiments on small laboratory animals exposed to ionizing radiation at lethal doses.

Methods

Animals were irradiated using a Puma gamma unit at an exposure dose rate of 2.31×10⁻⁵ A/kg: white mice received a dose of 7.9 Gy, and rats received 9.3 Gy. Each group consisted of six animals. Therapeutic agents were administered according to the following scheme: animals in group 1 received a single subcutaneous injection of anti-radiation serum (obtained from horses subjected to double irradiation) combined with bifidobacteria metabolism products (1 : 1 ratio) at a dose of 20 mg/kg 3 days after irradiation; animals in group 2 received anti-radiation serum alone at a dose of 50 mg/kg; animals in group 3 received no drugs (irradiation control). Animals in group 4 served as biological controls. Clinical condition, survival, average life span, hematological status, T and Blymphocyte content, and the intensity of lipid peroxidation were assessed. Statistical analysis was performed using GraphPad Prism 8.0; the significance of differences was assessed using Student’s ttest and Fisher’s test.

Results

Radiation exposure at the indicated doses caused 100% mortality in both mice and rats and was accompanied by statistically significant decreases: absolute leukocyte count by 68%, erythrocyte count by 27%, hemoglobin by 24%, hematocrit by 22%, total protein by 27%, and relative T and Blymphocyte content by 66% and 70%, respectively. An increase in malondialdehyde concentration in erythrocyte hemolysate and blood plasma by 56% and 53%, respectively, was also observed. Subcutaneous administration of anti-radiation serum at 50 mg/kg on day 3 after irradiation reduced the damaging effects of radiation, increasing survival of white mice and rats to 50% and extending average life span by 6% (mice) and 59% (rats). The combination of anti-radiation serum with bifidobacteria metabolism products produced a more pronounced antiradiation effect: animal survival reached 83.3% (p = 0.0076; p 0.05), and the degree of hematopoiesis suppression also reduced.

Conclusion

A single subcutaneous administration of anti-radiation blood serum combined with bifidobacteria metabolism products exerts an antiradiation effect, promotes restoration of hematological and immunological parameters, and increases survival of irradiated animals.

Zitieren

APA

Gaynutdinov, T. R., Boichuk, S. V., & Ryzhkin, S. A. (2026). The efficacy of anti-radiation blood serum in combination with bifidobacteria metabolism products on small laboratory animals: a pilot experimental study. Kazan medical journal, 107(3), 352-361. https://doi.org/10.17816/kmj690573

Vancouver

Gaynutdinov TR, Boichuk SV, Ryzhkin SA. The efficacy of anti-radiation blood serum in combination with bifidobacteria metabolism products on small laboratory animals: a pilot experimental study. Kazan medical journal. 2026;107(3):352-361. doi:10.17816/kmj690573

BibTeX
@article{Gaynutdinov2026,
  author = {Gaynutdinov, Timur R. and Boichuk, Sergey V. and Ryzhkin, Sergey A.},
  title = {The efficacy of anti-radiation blood serum in combination with bifidobacteria metabolism products on small laboratory animals: a pilot experimental study},
  journal = {Kazan medical journal},
  year = {2026},
  volume = {107},
  number = {3},
  pages = {352--361},
  doi = {10.17816/kmj690573}
}
Kostenlos starten →